Differential inhibition of herpes simplex viruses, type 1 (HSV-1) an type 2 (HSV-2), by (E)-5-(2-X-vinyl)-2'-deoxyuridines.
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D001973:Bromodeoxyuridine / Q000031:analogs & derivatives / Q000494:pharmacology; D002460:Cell Line; D003857:Deoxyuridine / Q000031:analogs & derivatives* / Q000494:pharmacology; D005468:Fluorodeoxyuridylate / Q000031:analogs & derivatives / Q000494:pharmacology; D007065:Idoxuridine / Q000031:analogs & derivatives / Q000494:pharmacology; D011817:Rabbits; D018139:Simplexvirus / Q000187:drug effects*; D013329:Structure-Activity Relationship
D000998:Antiviral Agents; D005468:Fluorodeoxyuridylate; C020235:brivudine; C030360:5-(2-iodovinyl)-2'-deoxyuridine; C032386:5-(1-propenyl)-2'-deoxyuridine; C019581:5-(3,3,3-trifluoro-1-propenyl)-2'-deoxyuridylate; C032385:5-(3,3,3-trifluoro-1-propenyl) 2'-deoxyuridine; C032024:5-(2-chlorovinyl)-2'-deoxyuridine; C032387:5-(2-cyanovinyl)-2'-deoxyuridine; D001973:Bromodeoxyuridine; D007065:Idoxuridine; D003857:Deoxyuridine